Silexion Therapeutics Ltd. ( SLXN) - Key Metrics
SLXN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $5.17 | -$4.26 | -$4.26 |
| 2026Q1 | $0 | -$8.46 | -$11.29 | -$11.29 |
| 2025Q4 | $0 | -$14.11 | -$9.65 | -$9.65 |
| 2025Q3 | $0 | -$28.80 | -$25.10 | -$25.10 |
| 2025Q2 | $0 | -$43.19 | -$43.26 | -$43.28 |
SLXN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.12 |
| 2026Q1 | 0% | -0.38 |
| 2025Q4 | 0% | -0.34 |
| 2025Q3 | 0% | -0.30 |
| 2025Q2 | 0% | -0.70 |
SLXN
Price: $0.38
52 week price:
Earnings Per Share: -58.82 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 569286